What the human evidence actually shows AOD-9604 has a surprisingly large paper trail for a peptidebecause it went through multiple controlled trials
Benfotiamine treats vitamin B1 deficiency and the nerve damage caused by this deficiency
Limitations of current studies When considering the limitations, not all studies used the same level of microscopic assessment, however, this is to be expected
Exploring the Buzz Around These Tiny Molecules Youve probably been hearing a lot about peptides lately
Additionally, as the first CVD to develop in patients with diabetes is often heart failure rather than myocardial infarction [1], it is becoming clear that the pathology of diabetes itself causes heart failure through direct effects on cardiomyocytes and other myocardial cell types
GLP3, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA